Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference
Heska Corporation (NASDAQ: HSKA) will participate in the 41st Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Heska Corporation (NASDAQ: HSKA) will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2023. Kevin Wilson, President & CEO, is scheduled to present at 9:45 a.m. PST. A live audio webcast of his presentation will be available online and archived for 90 days. Additionally, Heska management will engage in one-on-one meetings on the same day. Interested parties can contact J.P. Morgan or Heska's Investor Relations for meeting requests. For more details, visit the J.P. Morgan Healthcare Conference website.
Details
News Market Reaction – HSKA
The recorded move for HSKA in the trading session of this news was +2.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LOVELAND, Colo., Dec. 23, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska's management team will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Kevin Wilson, Heska's President & Chief Executive Officer, will present on Wednesday, January 11, 2023 at 9:45 a.m. Pacific Standard Time. A live audio webcast of Mr. Wilson's presentation will be available by visiting Heska J.P. Morgan 2023 Healthcare Conference Webcast. The webcast and presentation will be archived on the Company's website shortly after the event and a replay will be available for 90 days following the conference.
Mr. Wilson and members of Company management will also be participating in one-on-one meetings on January 11th. To request a meeting, please contact J.P. Morgan at 1x1@jpmorgan.com or Heska Investor Relations at investorrelations@heska.com.
For more information regarding the J.P. Morgan 2023 Healthcare Conference, visit J.P. Morgan Healthcare Conference Website.
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-to-participate-in-the-41st-jp-morgan-annual-healthcare-conference-301708831.html
SOURCE Heska Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.